We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Destiny Pharma Plc | LSE:DEST | London | Ordinary Share | GB00BDHSP575 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.25 | -1.37% | 18.00 | 17.50 | 18.50 | 18.25 | 18.00 | 18.25 | 225,759 | 15:40:10 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -6.5M | -0.0683 | -2.64 | 17.15M |
Date | Subject | Author | Discuss |
---|---|---|---|
12/4/2024 10:16 | henley2 agreed: and they were much heralded on return and arrival respectively. | carlisle44 | |
12/4/2024 10:13 | Will dip my toe in at 10p | the codger | |
12/4/2024 08:54 | I cannot see this going private based on the current share register. Henley is spot on with his post regarding the treatment of shareholders but this is AIM and rarely do these people get any admonishment for their lack of care for those that pay their outlandish salaries and perks. | marvelman | |
12/4/2024 08:45 | You either sell up, or if you can remain an investor in an unquoted company. You have to wonder wtf Rudd and Tovey are up to and why the Nomad is not forcing them to make a statement regarding the share price movement! | henley2 | |
12/4/2024 08:39 | Question :- As the chatter regarding the de-listing from AIM is now rise. What will happen to the existing shareholder in case of de-listing ? I guess Management will offer a price and we are forced to take it ? Thoughts ? | eva_1989 | |
12/4/2024 08:34 | Well here comes sub 20P Adding more.. | eva_1989 | |
11/4/2024 18:36 | Oh dear another biotech struggling after shoeing it's some way off and likely to need more funding. Given how far away this is I'm not surprised to see it falling eseoxailly now John Henry has bought. Will be suspended next lol.macd just turned negative again even after 2 days of falls. Chartooks horrific a bit like John's face lol | bones698 | |
11/4/2024 17:40 | Richard Henry ? Pips | pippa pinkerton | |
11/4/2024 16:43 | May I suggest you do some research into the companies that are listing and who has a big influence within that company? I'll give you a clue first name Richard. | john henry | |
11/4/2024 16:23 | Think they may follow etx and delist | bimbamboom | |
11/4/2024 11:52 | Eva PA certainly behaving like a possible fund raise doing the rounds however there has been a large seller for months so maybe today they throw the towel in and clear. | john henry | |
11/4/2024 11:48 | Added further today.. Fund raise indeed coming but r/r is high considering 1+ year hold Will add further sub 20p if i get. Building position now | eva_1989 | |
11/4/2024 11:47 | Dipped a toe back in a tad under 21p, have been out of these for a while but with the Mkt Cap dipping below £20M seems good Med term value. | john henry | |
11/4/2024 09:49 | Oh dear John Henry still. Backing losers are you. Told you it was heading south. Not sure why you referenced AGL at me all my shares there are totally free thanks | bones698 | |
10/4/2024 23:50 | Don’t worry, brooko said this was undervalued at 80p, what a prat | ttlance | |
10/4/2024 15:29 | The CEO's decision to push reformulation of M3 to the point where a rerun of Phase 2 may be required continues to look inexplicable. The emphasis on exploring all options to optimise value in recent RNS' does hint a going private as a possibility but their share holder register, with no large 10%+ holdings, might make getting support for it problematic. Once xf-73 dermal gets into Phase 1 for diabetic ulcers and burns things will look a bit better. ODT have been pusing their (very decent) tech for 10 years or more with neglible revs and no cash plus a similar burn rate to DEST. Neither co looks a good buy at the moment imo. Not clear whether either co can attract someone to fund a US P3 trial. Dest are at least in talks, ODT don't seem to be. | banshee | |
10/4/2024 13:09 | Certainly does if Steriwave has the same kill % as XF73 Which it appears too, | john henry | |
10/4/2024 12:35 | Thanks martinrai1950. Looks bad news for XF73. | jias | |
10/4/2024 08:30 | Spot on Henley imho over the next few years the UK will lose a complete sector in Biotech/Tech. | john henry | |
10/4/2024 07:43 | E-Therapeutics the next company going private. Reading their RNS tells you everything that is wrong with the AIM market. Destiny next? | henley2 | |
09/4/2024 16:03 | And what of Sir Nigel thus far? | carlisle44 | |
09/4/2024 10:29 | More interested in announcement of deals they are negotiating. New CEO was praised but so far achieved nothing. Except crashing share price.IMHO | mam fach | |
08/4/2024 17:22 | Hopefully someone will ask at the Investor Meet whether or not there is a chance of this going private???? With REDX in mind! | wh1spa |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions